rs3815484
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_018685.5(ANLN):c.2883+18C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.119 in 1,512,408 control chromosomes in the GnomAD database, including 11,895 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.10 ( 941 hom., cov: 31)
Exomes 𝑓: 0.12 ( 10954 hom. )
Consequence
ANLN
NM_018685.5 intron
NM_018685.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.503
Genes affected
ANLN (HGNC:14082): (anillin, actin binding protein) This gene encodes an actin-binding protein that plays a role in cell growth and migration, and in cytokinesis. The encoded protein is thought to regulate actin cytoskeletal dynamics in podocytes, components of the glomerulus. Mutations in this gene are associated with focal segmental glomerulosclerosis 8. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 7-36427046-C-A is Benign according to our data. Variant chr7-36427046-C-A is described in ClinVar as [Benign]. Clinvar id is 261049.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.21 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANLN | NM_018685.5 | c.2883+18C>A | intron_variant | ENST00000265748.7 | NP_061155.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANLN | ENST00000265748.7 | c.2883+18C>A | intron_variant | 1 | NM_018685.5 | ENSP00000265748.2 | ||||
ANLN | ENST00000396068.6 | c.2772+18C>A | intron_variant | 1 | ENSP00000379380.2 | |||||
ANLN | ENST00000457743.1 | c.492+18C>A | intron_variant | 5 | ENSP00000399553.1 | |||||
ANLN | ENST00000428612.5 | c.375+18C>A | intron_variant | 5 | ENSP00000413522.1 |
Frequencies
GnomAD3 genomes AF: 0.102 AC: 15501AN: 151772Hom.: 944 Cov.: 31
GnomAD3 genomes
AF:
AC:
15501
AN:
151772
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.125 AC: 27850AN: 222756Hom.: 1949 AF XY: 0.128 AC XY: 15427AN XY: 120588
GnomAD3 exomes
AF:
AC:
27850
AN:
222756
Hom.:
AF XY:
AC XY:
15427
AN XY:
120588
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.121 AC: 164719AN: 1360522Hom.: 10954 Cov.: 21 AF XY: 0.122 AC XY: 83294AN XY: 680110
GnomAD4 exome
AF:
AC:
164719
AN:
1360522
Hom.:
Cov.:
21
AF XY:
AC XY:
83294
AN XY:
680110
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.102 AC: 15510AN: 151886Hom.: 941 Cov.: 31 AF XY: 0.105 AC XY: 7763AN XY: 74206
GnomAD4 genome
AF:
AC:
15510
AN:
151886
Hom.:
Cov.:
31
AF XY:
AC XY:
7763
AN XY:
74206
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
628
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 29, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at